Rubius Therapeutics is biologically engineering red blood cells to provide a new class of ... likely to cause toxicity due to extravascular target engagement. Rubius Therapeutics’s RED PLATFORM ...
Africa and Europe say they have identified a potential new gene target that could be edited to treat sickle cell disease, an ...
Researchers identified an enzyme that helps Plasmodium-infected red blood cells adhere to the placenta ... especially to selectively target the parasitic CK2α without harming the human enzyme.
Scientists say they have identified a potential new gene target that could be edited to treat sickle cell disease, an ...
Pharmaceutical Technology on MSN2d
FDA awards ODD status to Sanofi’s rilzabrutinib for two rare conditionsSanofi's oral, reversible Bruton’s tyrosine kinase (BTK) inhibitor rilzabrutinib has gained US Food and Drug Administration ...
CD163 is a macrophage receptor that clears hemoglobin-haptoglobin complexes from blood, preventing oxidative damage and also ...
There are four components - or parts - of the blood: red blood cells, white blood cells, plasma and platelets. Blood carries things you need, like oxygen and glucose, and waste products ...
Scientists have found a potential new gene variant target to treat sickle cell disease, an inherited blood disorder that ...
Identifying the JAK2V617F mutation has improved understanding of what causes overproduction of red blood cells, platelets, and neutrophils in polycythemia vera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback